Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↓ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ | Insider net 12M ↓ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVCTNuvectis Pharma, Inc. | 2025 | 43 | $641.5M | $19.69 | -6.77% | — | -118.30% | — | — | 4 | $2.3M |